Skip to content

Startup & venture capital news

Galvanize Therapeutics raises USD 130m Series D

HealthQuest Capital leads financing for pulsed electric field devices.

By /

LinkedInX
Galvanize Therapeutics: Galvanize Therapeutics raises USD 130m Series D

Galvanize Therapeutics closed an oversubscribed USD 130 million Series D led by HealthQuest Capital. Olympus Innovation Ventures and Braidwell joined as new investors, alongside existing backers. The Redwood City company develops pulsed electric field technologies for oncology and chronic lung disease. It says the financing will support commercial expansion of its Aliya platform, clinical evidence work, advancement of RheOx therapy and development of next-generation products. Regulatory, procedure and performance claims remain company reported. The amount, stage, lead and announced use of funds were confirmed through the company release and separate adviser coverage.

Keep reading

More Funding

All stories